bismuth and actinium
bismuth has been researched along with actinium in 41 studies
Research
Studies (41)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (12.20) | 18.7374 |
| 1990's | 4 (9.76) | 18.2507 |
| 2000's | 10 (24.39) | 29.6817 |
| 2010's | 16 (39.02) | 24.3611 |
| 2020's | 6 (14.63) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Benoan, F; Hu, SJ; Kandaiya, S | 1 |
| Kaubisch, N; Kemmer, J; Stronski, I | 1 |
| Dvorák, V; Malátová, I | 1 |
| Parr, RM | 1 |
| Coats, GI; Goldin, AS; Kauffman, PE; Magno, PJ | 1 |
| Apostolidis, C; Bos, E; Doornmalen, AV; Geerlings, MW; Kaspersen, FM; Molinet, R | 1 |
| Featherstone, C | 1 |
| Finn, RD; Ma, D; McDevitt, MR; Scheinberg, DA; Sgouros, G | 1 |
| Finn, RD; Larson, SM; Ma, D; McDevitt, MR; Scheinberg, DA | 1 |
| Imam, SK | 1 |
| Finn, RD; Ma, D; McDevitt, MR; Scheinberg, DA | 1 |
| Lin, HY; McDevitt, MR; Scheinberg, DA; Sgouros, G; Sofou, S; Thomas, JL | 1 |
| Pozzi, OR; Zalutsky, MR | 1 |
| Anderson, T; Atcher, R; Nayak, T; Norenberg, J | 1 |
| Cabassa, C; Flombaum, CD; Jaggi, JS; Kappel, BJ; McDevitt, MR; Scheinberg, DA; Sgouros, G | 1 |
| Allen, BJ | 2 |
| Casadevall, A; Dadachova, EA; Howell, RC; Schweitzer, AD | 1 |
| Blázquez, S; Camacho, A; Ortega, X; Pérez, S; Serrano, I; Vallés, I | 1 |
| Apostolidis, C; Esaias, C; Hobbs, RF; Huso, DL; Morgenstern, A; Sgouros, G; Song, H; Vajravelu, R | 1 |
| Humm, JL; Jaggi, JS; Larson, SM; McDevitt, M; O'Donoghue, JA; Ruan, S; Scheinberg, DA; Schwartz, J | 1 |
| Blechert, B; Bruchertseifer, F; Essler, M; Gärtner, FC; Morgenstern, A; Neff, F; Seidl, C; Senekowitsch-Schmidtke, R | 1 |
| Apostolidis, C; Bruchertseifer, F; Morgenstern, A | 2 |
| Lanzo, G; Rizzo, S; Tomarchio, E | 1 |
| Bruchertseifer, F; de Kruijff, RM; Denkova, AG; Mendes, E; Morgenstern, A; Rol, A; Stuart, MC; Thijssen, L; Wang, G; Wolterbeek, HT | 1 |
| Akudugu, JM; Domogauer, JD; Howell, RW; Khullar, A; Pasternack, JB | 1 |
| Batista, ER; Birnbaum, ER; Engle, JW; Fassbender, ME; Ferrier, M; John, KD; Maassen, JR; Martin, RL; Nortier, FM; Radchenko, V; Wilson, JJ | 1 |
| Al-Ramady, AM; Nafee, SS; Shaheen, SA | 1 |
| Apostolidis, C; Bruchertseifer, F; Kratochwil, C; Krolicki, L; Morgenstern, A; Sathekge, M | 1 |
| Jurcic, JG | 1 |
| Bednarz, B; Lee, D; Li, M; Schultz, MK | 1 |
| Knapp, FFR; Radchenko, V; Schaffer, P | 1 |
| Bruchertseifer, F; Kellerbauer, A; Malmbeck, R; Morgenstern, A | 1 |
| Bruchertseifer, F; Morgenstern, A | 1 |
| Ferrier, MG; Radchenko, V | 1 |
| Dizdarevic, S; McCready, R; Vinjamuri, S | 1 |
| Ji, NT; Karimian, A; Sgouros, G; Song, H | 1 |
| Bruchertseifer, F; Jakuciński, M; Koziara, H; Królicki, B; Królicki, L; Kunikowska, J; Merlo, A; Morgenstern, A; Pawlak, D; Rola, R; Rosiak, E | 1 |
| Allen, KJH; Dadachova, E; de Klerk, JMH; Helal, M; Lam, MGEH; van der Wal, BCH; van Dijk, B; Vogely, HC; Weinans, H | 1 |
| Aggarwal, R; Ali, U; Beckford-Vera, D; Bidkar, AP; Bidlingmaier, S; Bobba, KN; Chan, E; Chou, J; Dasari, C; Dhrona, S; Egusa, EA; Flavell, RR; He, J; Liu, B; Meher, N; Peter, R; Seo, Y; Su, Y; Tang, R; VanBrocklin, HF; Wadhwa, A; Wang, S; Wilson, DM; Zhang, L | 1 |
Reviews
11 review(s) available for bismuth and actinium
| Article | Year |
|---|---|
Advancements in cancer therapy with alpha-emitters: a review.
Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Astatine; Beta Particles; Bismuth; Cell Death; Energy Transfer; Fermium; Humans; Immunoconjugates; Neoplasms; Radioisotopes; Radium; Relative Biological Effectiveness; Terbium | 2001 |
Radioimmunotherapy with alpha-particle emitting radionuclides.
Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Astatine; Bismuth; Humans; Isotopes; Neoplasms; Practice Patterns, Physicians'; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Treatment Outcome | 2004 |
Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
Topics: Actinium; Aged; Aged, 80 and over; Alpha Particles; Animals; Bismuth; Clinical Trials as Topic; Humans; Mice; Mice, Transgenic; Middle Aged; Neoplasms; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals | 2012 |
An Overview of Targeted Alpha Therapy with
Topics: Actinium; Alpha Particles; Bismuth; Clinical Trials as Topic; Humans; Neoplasms; Radiochemistry; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals | 2018 |
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies.
Topics: Actinium; Alpha Particles; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bismuth; Clinical Trials as Topic; Humans; Leukemia, Myeloid, Acute; Radiochemistry; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals | 2018 |
Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.
Topics: Actinium; Alpha Particles; Bismuth; Humans; Radiochemistry; Radioisotopes; Radiotherapy | 2019 |
Development of Targeted Alpha Therapy from Bench to Bedside.
Topics: Actinium; Alpha Particles; Bismuth; History, 20th Century; History, 21st Century; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy | 2019 |
An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Topics: Actinium; Alpha Particles; Astatine; Bismuth; Humans; Neoplasms; Radioisotopes; Radiotherapy; Radium; Thorium | 2019 |
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.
Topics: Actinium; Astatine; Bismuth; Bone Neoplasms; Humans; Lead Radioisotopes; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Thorium | 2020 |
Supply and Clinical Application of Actinium-225 and Bismuth-213.
Topics: Actinium; Bismuth; Humans; Isotope Labeling; Male; Prostatic Neoplasms; Radioisotopes | 2020 |
Topics: Actinium; Bismuth; Glioma; Humans; Radioisotopes; Substance P | 2020 |
Other Studies
30 other study(ies) available for bismuth and actinium
| Article | Year |
|---|---|
Gamma activity in struverite.
Topics: Actinium; Bismuth; Gamma Rays; Lead; Radioisotopes; Radium; Thailand; Thallium; Titanium | 1987 |
[Separation of MsTh1-MsTh2 and ThB-ThC, using extraction chromatography in the di(ethylhexyl)-phosphoric acid-HC1 system].
Topics: Actinium; Bismuth; Chlorides; Chromatography; Lead; Phosphoric Acids; Radioisotopes; Radium; Salts; Spectrum Analysis; Thorium | 1968 |
Results of the whole-body counting of patients with known amount of injected thorotrast.
Topics: Actinium; Adult; Aged; Bismuth; Body Burden; Femoral Artery; Humans; Male; Middle Aged; Potassium Isotopes; Radiography; Radioisotopes; Radiometry; Thallium; Thorium; Thorium Dioxide; Whole-Body Counting | 1970 |
Information on thorotrast dosimetry supplied by the radiochemical analysis of tissue specimens.
Topics: Actinium; Adrenal Glands; Bismuth; Bone and Bones; Bone Marrow; Humans; Intestines; Kidney; Lead; Liver; Lung; Methods; Muscles; Myocardium; Pancreas; Polonium; Radioisotopes; Radiometry; Radium; Radon; Spleen; Thallium; Thorium Dioxide; Thyroid Gland; Time Factors | 1967 |
Measurement of thorium and daughter products in tissue: effect of time on the results.
Topics: Actinium; Bismuth; Follow-Up Studies; Humans; Lead; Liver; Polonium; Radioisotopes; Radiometry; Radium; Radon; Spleen; Thallium; Thorium; Thorium Dioxide; Time Factors | 1967 |
Cytotoxicity of 213Bi- and 225Ac-immunoconjugates.
Topics: Actinium; Animals; Antibody Specificity; Bismuth; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Humans; Immunoconjugates; Immunoglobulin G; Kinetics; Mice; Pentetic Acid; Radioisotopes; Tumor Cells, Cultured | 1995 |
Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
Topics: Actinium; Alpha Particles; Bismuth; Humans; Leukemia, Myeloid, Acute; Radioimmunotherapy; Radioisotopes | 1997 |
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.
Topics: Actinium; Alpha Particles; Bismuth; Isotope Labeling; Nuclear Medicine; Radioisotopes; Radionuclide Generators | 1999 |
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
Topics: Actinium; Algorithms; Alpha Particles; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Bismuth; Clinical Trials, Phase I as Topic; Humans; Isotope Labeling; Leukemia, Myeloid; Quality Control; Radioisotopes; Sialic Acid Binding Ig-like Lectin 3 | 1999 |
Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator: development of new methods, quantitative characterization, and implications for clinical use.
Topics: Actinium; Bismuth; Francium; Humans; Lead Radioisotopes; Leukemia; Radiochemistry; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals | 2001 |
Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Liposomes; Microscopy, Electron; Neoplasm Metastasis; Radioisotopes | 2004 |
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin | 2005 |
Efforts to control the errant products of a targeted in vivo generator.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Chelating Agents; Female; Francium; Immunotoxins; Kidney; Lymphoma; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Radioimmunotherapy; Succimer; Unithiol | 2005 |
Addendum to: Basic immunology of antibody targeted radiotherapy: in regard to Wong (Int J Radiat Oncol Biol Phys 2006;66: S8-S14).
Topics: Actinium; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Bismuth; Chondroitin Sulfate Proteoglycans; Humans; Membrane Proteins; Neoplasms; Radioimmunotherapy; Radioisotopes | 2007 |
Chemosorption of radiometals of interest to nuclear medicine by synthetic melanins.
Topics: Actinium; Adsorption; Bismuth; Cysteine; Dopamine; Gamma Rays; Indium Radioisotopes; Levodopa; Melanins; Nuclear Medicine; Radiochemistry; Scintillation Counting; Tyrosine | 2008 |
Natural and anthropogenic radionuclides in airborne particulate samples collected in Barcelona (Spain).
Topics: Actinium; Air Pollutants, Radioactive; Beryllium; Bismuth; Lead; Particulate Matter; Radioisotopes; Seasons; Spain; Thallium | 2009 |
Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Immunotoxins; Isotope Labeling; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2; Tissue Distribution; Yttrium Radioisotopes | 2009 |
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody.
Topics: Actinium; Animals; Antibodies; Autoradiography; Biological Transport; Bismuth; Female; Humans; Kidney; Mice; Mice, Inbred BALB C; Radiation Dosage; Radioisotopes; Radiometry | 2011 |
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Organometallic Compounds; Pentetic Acid; Peptides; Peritoneal Neoplasms; Radioisotopes; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
A radiometric and petrographic approach to risk assessment at Alte Madonie Mounts region (Sicily, Italy).
Topics: Actinium; Background Radiation; Bismuth; Geography; Linear Models; Potassium; Radiation Monitoring; Radioisotopes; Radiometry; Radium; Risk Assessment; Sicily; Soil Pollutants, Radioactive; Spectrometry, Gamma; Thorium; Uranium | 2014 |
Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles.
Topics: Actinium; Alpha Particles; Biological Transport, Active; Bismuth; Butadienes; Drug Compounding; Francium; HeLa Cells; Humans; Lead Radioisotopes; Monte Carlo Method; Particle Size; Polyethylene; Radioisotopes; Radiopharmaceuticals | 2014 |
The advantage of antibody cocktails for targeted alpha therapy depends on specific activity.
Topics: Actinium; Algorithms; Alpha Particles; Antibodies; Astatine; Bismuth; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Combinations; Female; Humans; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals | 2014 |
Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes.
Topics: Actinium; Alpha Particles; Binding, Competitive; Bismuth; Chelating Agents; Edetic Acid; Isotope Labeling; Kinetics; Ligands; Macrocyclic Compounds; Nitrogen; Quantum Theory; Radioisotopes | 2015 |
Nuclear Data Evaluation for Mass Chain A=217:Odd-Proton Nuclei.
Topics: Actinium; Alpha Particles; Astatine; Bismuth; Electrons; Francium; Gamma Rays; Half-Life; Probability; Protactinium; Protons; Radioisotopes; Synchrotrons; Thallium | 2016 |
A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
Topics: Actinium; Alpha Particles; Bismuth; DNA Repair; Humans; Neoplasms; Organ Sparing Treatments; Radioisotopes; Radiopharmaceuticals | 2017 |
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes | 2018 |
The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Neoplasms; Radiochemistry; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals | 2018 |
Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Breast Neoplasms; Cell Line, Tumor; Diffusion Magnetic Resonance Imaging; Disease Management; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Image Processing, Computer-Assisted; Mice; Mice, Transgenic; Models, Biological; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-2; Single Photon Emission Computed Tomography Computed Tomography | 2020 |
Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms.
Topics: Actinium; Antibodies, Monoclonal; Biofilms; Bismuth; Humans; In Vitro Techniques; Lutetium; Methicillin-Resistant Staphylococcus aureus; Plankton; Proof of Concept Study; Prosthesis-Related Infections; Radioimmunotherapy; Radioisotopes; Staphylococcal Infections; Teichoic Acids | 2020 |
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.
Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Male; Membrane Cofactor Protein; Mice; Prostatic Neoplasms; Radioimmunotherapy; Radioisotopes; Tissue Distribution | 2023 |